Rejected

Proton-pump inhibitors (PPIs) are commonly utilized in the treatment of upper gastrointestinal bleeds (UGIBs) due to their ability to stabilize blood clot formation. PPIs have been shown to reduce rebleeding after endoscopic hemostasis and reduce signs of bleeding at index endoscopy. While PPIs are well-tolerated and commonly administered to patients suffering from acute UGIBs, significant adverse effects may occur. Patients have reported various mild systemic symptoms during short-term PPI use, including headache, rash, dizziness, nausea, abdominal pain, flatulence, constipation, and diarrhea. In general, serious side effects of PPIs tend to be mild during treatment periods under two weeks; however, as the treatment duration increases, side effects have been observed to increase in frequency and severity. PPI-induced thrombocytopenia is an exceedingly rarely reported adverse reaction that remains largely unstudied due to the dearth of patient cases. This adverse effect continues to be a diagnosis of exclusion, and there are no current evidence-based recommendations to approach this complication. Thrombocytopenia increases the risk of rebleeding and hemodynamic instability, which may be devastating to patients suffering from UGIBs. Here, we present a case of thrombocytopenia that began after the introduction of pantoprazole in the setting of a UGIB. The thrombocytopenia resolved promptly after cessation of the medication. We highlight this case to increase awareness of this rare finding given the lack of recommendations for short-term PPI-induced thrombocytopenia.

Well delineated precipitating factors of migraine or incapacitating headaches are well known in the literature. Few peculiar and under-recognized precipitants are crying, shouting, straining in stools, urination, orgasm, childbirth, powerlifting. We present a case of a young student whose laughing aloud is a potent headache precipitant and is consistently reproducible despite normal brain imaging. It is worth mentioning here that laugh-induced headache has recently been assigned a place in the International Classification of Headache Disorders (ICHD-III) in 2018. The proposed pathophysiology in our case could be loud laugh induced Valsalva maneuver raising intra-abdominal and intra-thoracic pressure momentarily causing venous congestion of head presenting as episodic headache. Another plausible explanation related to craniospinal pressure dissociation and the concept of dural elasticity and compliance needs to be explored if the symptoms persist and repeat scans show no pathology. Momentarily rise of intracranial pressure due to vigorous laugh could press the tonsils or distal cerebellar portion to herniate down transiently, causing symptoms and may be back to normal position once the laugh ceases. Social laughter releases enormous endogenous opioids, which is supported using positron emission tomography (PET) and u-opioid-receptor (MOR)-specific ligand carfentanil. A mirthful laugh could trigger a primary laugh headache. The role of modulated opioidergic activity and social mirthful laugh, if connected with such rare headaches requires further study.

Malignant tumors of the seminal vesicles are rare; they may be of epithelial or mesenchymal origin. Carcinomas are the most common and pelvic sarcoma may be confused with a primary tumor of the seminal vesicles. Little is known of the prognosis and best sequence of treatment in such sarcoma. We report a rare case of extra-skeletal Ewing sarcoma/primitive neuroectodermal tumor of the seminal vesicles in a 54-year-old man who presented with chronic lower abdominal pain, urinary retention, and severe constipation. Pelvic CT scan and MRI confirmed the presence of a soft tissue mass lesion centered on seminal vesicles. A trans-gluteal Tru-cut biopsy confirmed the diagnosis. Three cycles of the preoperative chemotherapy VAC/IE (vincristine, Adriamycin and cyclophosphamide, followed by ifosfamide and etoposide) protocol achieved an excellent clinical response.

The phenomenon of pain remains one of the most important challenges in medicine and biology, which often causes disability in humans and worsens the quality of life. The pain is a variable, subjective experience, and it is impossible to fully understand it without getting to know the physiological mechanisms beyond sensory damage of the tissues. There are some gender differences in pain perception, particularly, females tend to be more sensitive towards experimental pain. Interestingly, the observed data is consistent for males throughout life, but as for females, parameters vary according to the age and ovarian-menstrual cycle (OMC) phases. Study aims to assess correlation between pain perception and indices of hostility in males and females (in the follicular phase of OMC cycle). The sample of this study included volunteer students, ages 18 to 23. The main selection criterium for participants was their health state; Those without chronic pain, excess body weight (assessed by BMI), cardiovascular, respiratory, endocrine, etc. disorders were selected for participation in the study. Prior to the start of the study, participants were given information about their rights and written informed consent was obtained. Participants were informed that they could refuse to take part in the study at any stage. All procedures and protocol of the study were approved by Tbilisi State Medical University Biomedical Research Committee. The study was conducted in compliance with all requirements and regulations of International Pain Association for biomedical observation and experiments. Ovarian-menstrual cycle of the women participating in the research were evaluated using relevant questionnaires. All experiments were performed in the follicular phase of menstrual cycle (7-11 days of the cycle). At this stage, study was conducted in starvation state- 10-12 hours after the last meal. According to our experiment, the findings about gender differences of psychologic parameters and their linkage to heat and cold sensitivity coincides with previous study results, where pain threshold and tolerance to the pain are positively correlated with high degree of assault. Our findings demonstrate that pain perception by humans, besides intensity of nociceptive stimuli, depends on psychophysiologic parameters. The findings correlate with the data from previous studies, particularly to the idea, that negative emotions and different types of assault define individual correlates of pain perception, pain threshold and tolerance to the pain. It is quite clear that further research is warranted in order to make evidence-based statements and recommendations for clinical practice, including treatment protocols for pain management. It is quite possible, that in near future, assessing psychoemotional condition will be one of the most important tools in pain management. Besides, by evaluating psychoemotional parameters, it may become possible to predict the probability of progressing acute pain into chronic pain, which will be essential predictive information to decrease the risk of disease chronization.

Fractures are increasing worldwide and with an aging population, are frequent in the elderly. The healing of fractures progresses through various phases including the inflammatory stage. Aging is associated with slower healing and the use of non steroidal anti-inflammatory drugs (NSAIDs) may interrupt bone healing processes. We designed a study to compare the effect of diclofenac and celecoxib on fracture callus histomorphometry in a rat model of different age groups.

Vestibular migraine （VM） is one of the common vestibular diseases characterized by recurrent vertigo and migraine. Studies have shown that the sleep structure of VM patients is similar to that of migraine patients, and they have a common pathophysiological pathogenesis. There is a strong correlation between VM and the clinical symptoms of sleep disorders. Sleep disorders can trigger VM. On the contrary, VM can affect sleep regulatory centers and lead to structural sleep disorders. In addition, there is a common relationship between VM and sleep disorders in neuroanatomy, neurotransmitters and neural pathways. A correct understanding of the relationship between vestibular migraine and sleep disorders can provide some help for clinical diagnosis and treatment. This article reviews the relationship between vestibular migraine and the pathogenesis of sleep disorders.

Clinical manifestations of biological aging can be remarkably similar to the side effects of frequently used medications. Fatigue, muscle pain, and confusion are common and often not shared as part of proper geriatric patient history. When patients report them, a root cause is usually confounding. These symptoms not only negatively impact health and wellness outcomes, patient quality of life, and increase costs to the healthcare system, but also may be a limitation on provider best practices. The patient, a 71-year-old female of European descent, enrolled in pharmacogenomics-enriched comprehensive medication management (PGx+CMM) program through her retirement benefit. At the time of testing, she was approximately 18 months post cerebrovascular accident and was being observed by her primary care provider for common chronic conditions. Of interest, she had been manifesting unreported clinical symptoms of fatigue, hypotension, and myalgia. Addressing these patient concerns and specifically focusing on an individual's goals, fears, and basic needs, rather than concentrating merely on the absence of disease, is the crux of personalized medicine and programs that address the notion of healthy aging. The patient's therapeutic regimen was adjusted based on PGx+CMM pharmacist review, use of a clinical decision support system (CDSS), and communication of recommendations to the prescribing physician. The patient saw rapid improvements in symptoms, suggesting they were caused by medication side effects. Her blood pressure and cholesterol levels remained controlled while noticeable side effects were eliminated. This case study demonstrates the positive impacts of personalized medicine and shows how pharmacists can be empowered with a CDSS to positively impact healthcare.

Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is characterized by metabolic stroke, seizures, cognitive decline, lactic acidosis, ragged-red fibers, headache, and vomiting, and in 80% of cases due to the mtDNA variant m.3243A>G. We report the case of a MELAS patient carrying a variant in subunit-5 of the respiratory chain (-), rarely reported in MELAS. The patient is a 33-year-old male, who experienced a series of stroke-like episodes (StLEs) since age 23 years, which manifested clinically as seizures transient sensory disturbances, weakness, and visual or cognitive impairment. Over 9 years, these StLEs were misinterpreted as ischemic strokes, respectively, as cerebral vasculitis. He presented with mild, recurrent elevations of the creatine kinase. Initially, anti-seizure drugs and steroids appeared to be beneficial. Despite good recovery of each single StLE, the patient experienced a progressive decline of cognitive functions and activities of daily living. Cerebral imaging showed corresponding stroke-like lesions in changing locations. At age 32y, genetic work-up revealed the variant m.13513G>A in -. The patient profited significantly from a cocktail with anti-oxidants/cofactors. This case shows that the variant m.13513G>A in – can manifest as MELAS that StLEs recover spontaneously and that the course of MELAS is slowly progressive.

To evaluate the efficacy and safety of transcatheter arterial embolization for the treatment of chronic inflammatory joint pain via a systematic review and meta-analysis.